| __timestamp | Teva Pharmaceutical Industries Limited | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 5078000000 | 381287000 |
| Thursday, January 1, 2015 | 4717000000 | 452612000 |
| Friday, January 1, 2016 | 5096000000 | 316800000 |
| Sunday, January 1, 2017 | 4986000000 | 330100000 |
| Monday, January 1, 2018 | 4214000000 | 265800000 |
| Tuesday, January 1, 2019 | 3806000000 | 336200000 |
| Wednesday, January 1, 2020 | 3671000000 | 423900000 |
| Friday, January 1, 2021 | 3528000000 | 467000000 |
| Saturday, January 1, 2022 | 3445000000 | 487000000 |
| Sunday, January 1, 2023 | 3498000000 | 477100000 |
| Monday, January 1, 2024 | 3702000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, understanding spending patterns can offer valuable insights into a company's strategic priorities. Over the past decade, Teva Pharmaceutical Industries Limited and United Therapeutics Corporation have demonstrated contrasting approaches in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, Teva's SG&A expenses have seen a significant decline of approximately 31%, from a peak in 2016. This reduction reflects a strategic shift towards cost optimization, possibly in response to market pressures and the need to maintain profitability.
Conversely, United Therapeutics has shown a steady increase in SG&A spending, growing by about 25% over the same period. This upward trend suggests a focus on expansion and investment in marketing and administrative capabilities.
These spending patterns highlight the diverse strategies employed by pharmaceutical companies to navigate the ever-evolving healthcare landscape.
Eli Lilly and Company and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and United Therapeutics Corporation
Operational Costs Compared: SG&A Analysis of AbbVie Inc. and United Therapeutics Corporation
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or United Therapeutics Corporation
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Veracyte, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited and Geron Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Biogen Inc. and United Therapeutics Corporation
Who Optimizes SG&A Costs Better? United Therapeutics Corporation or ADMA Biologics, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Wave Life Sciences Ltd.
United Therapeutics Corporation vs Travere Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Viridian Therapeutics, Inc.